Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, shares recent ...

Aurora Cannabis Inc. closed 49.29% below its 52-week high of $6.67, which the company reached on October 9th. Supported by world-class markets data from Dow Jones and FactSet, and partnering with ...

View Aurora Cannabis Inc. ACB stock quote prices, financial information, real-time forecasts, and company news from CNN.

Detailed price information for Aurora Cannabis Inc (ACB-Q) from The Globe and Mail including charting and trades.

Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to ...

Canadian grant protects Aurora‑developed genetics bred through the company's advanced research and breeding program "These plant breeders' rights recognize the depth of work behind our leading ...

Detailed price information for Aurora Cannabis Inc (ACB-Q) from The Globe and Mail including charting and trades.

Q1 launches reinforce Aurora's medical‑first strategy, expanding access to high‑quality products across multiple formats Scaled launches across Canada, Europe and Australia support growing demand in ...

Nasdaq Composite cannabis companies faced renewed uncertainty as a legal challenge to federal rescheduling added complexity ...

Cannabis sector developments within the Nasdaq Composite highlight evolving medical cannabis regulations, legal proceedings, ...

Canadian grant protects Aurora‑developed genetics bred through the company's advanced research and breeding program EDMONTON, AB, May 14, 2026 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ...